AH

Akhtar Husain Mohammad Ismail

Active Director Director DIN 08501657
DIN 08501657 First appointment Jul 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Akhtar Husain Mohammad Ismail

Data last updated:

Akhtar Husain Mohammad Ismail is a Director at Knewera Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals.

DIN 08501657
Primary Designation Director
Industry Chemicals
First Appointment 05 Jul 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jul 20192019Active

Board colleagues of Akhtar Husain Mohammad Ismail

Directorship timeline

Open interactive timeline →
Knewera Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Akhtar Husain Mohammad Ismail

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhtar Husain Mohammad Ismail

Akhtar Husain Mohammad Ismail currently holds 1 directorship: Knewera Pharmaceuticals Private Limited (Director, since 05 Jul 2019).

Akhtar Husain Mohammad Ismail was first appointed on 05 Jul 2019 as Director at Knewera Pharmaceuticals Private Limited.

The current boards of Akhtar Husain Mohammad Ismail's companies include Ansari Mohammad Aasif Mohammad Saleem (Knewera Pharmaceuticals Private Limited), Azhar Jameel Sarfaraz Ahmad Ansari (Knewera Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available